Clinic
Alegent Health - Mercy Hospital, Corning Iowa
Alegent Health - Mercy Hospital, Corning Iowa was paid $257K by Medicaid between Jan 2018 and Nov 2024, across 26 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoALEGENT HEALTH - MERCY HOSPITAL, CORNING IOWA
CORNING, IA 50841
CORNING, IA 50841
33aNPI1699856260assigned 10/18/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$257K
24GClaims4,936
24DCodes billed26
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Iowa
Rank by total paid#12 of 25
Median peer was paid$194K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 738 | $24K | |
| 2019 | 226 | $10K | |
| 2020 | 180 | $12K | |
| 2021 | 337 | $18K | |
| 2022 | 1,428 | $60K | |
| 2023 | 1,401 | $85K | |
| 2024incomplete | 626 | $47K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 415 | 320 | $52K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 268 | 210 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14% | 1,387 | 1,145 | $36K |
| 80053 | Comprehensive metabolic panel | 12% | 494 | 399 | $30K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 7.3% | 138 | 115 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 614 | 287 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.5% | 98 | 88 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.1% | 57 | 53 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 356 | 327 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 114 | 98 | $6K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.9% | 234 | 202 | $5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 84 | 81 | $4K |
14 more codes
| J7030 | Infusion, normal saline solution , 1000 cc | 1.7% | 60 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 82 | $2K |
| 87070 | <1% | 155 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 64 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 28 | $2K |
| 87807 | <1% | 72 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $906.37 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 31 | $839.52 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 39 | $835.53 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 57 | $554.85 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 15 | $478.22 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15 | $430.79 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 17 | $40.70 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUIPER, EVERT (CEO - CHI HEALTH)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.